Riociguat (BAY 63‐2521) and Aspirin: A Randomized, Pharmacodynamic, and Pharmacokinetic Interaction Study-Reference-Cited by-同舟云学术

Riociguat (BAY 63‐2521) and Aspirin: A Randomized, Pharmacodynamic, and Pharmacokinetic Interaction Study

Published:2016-03 Issue:S1 Volume:6 Page:
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Frey Reiner¹,Reber Michael¹,Krätzschmar Jörn¹,Unger Sigrun²,Mück Wolfgang¹,Wensing Georg¹

Affiliation:

1. Clinical PharmacologyPharma Research CenterBayer PharmaWuppertalGermany

2. Global BiostatisticsPharma Research CenterBayer PharmaWuppertalGermany

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1086/685014

Reference29 articles.

1. Soluble Guanylate Cyclase: A New Therapeutic Target for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

2. Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease

3. Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

4. Riociguat for the Treatment of Pulmonary Arterial Hypertension

5. US Food and Drug Administration.Prescribing information [Adempas (riociguat) tablets]. Revised May2014.http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204819s002lbl.pdf.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacodynamic and Pharmacokinetic Interaction Profile of Vericiguat: Results from Three Randomized Phase I Studies in Healthy Volunteers;Clinical Pharmacokinetics;2020-10-08

2. Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects;Clinical Drug Investigation;2019-09-24

3. In vitro assessment of P‐gp and BCRP transporter‐mediated drug–drug interactions of riociguat with direct oral anticoagulants;Fundamental & Clinical Pharmacology;2019-08-28

4. A focus on riociguat in the treatment of pulmonary arterial hypertension;Basic & Clinical Pharmacology & Toxicology;2019-07-04

5. Practical management of riociguat in patients with pulmonary arterial hypertension;Therapeutic Advances in Respiratory Disease;2019-01